Skip to main content
Premium Trial:

Request an Annual Quote

Strategic Diagnostics to Supply Antibodies for SAIC, NCI Proteomic Studies

NEW YORK (GenomeWeb News) – Strategic Diagnostics said yesterday that it will provide monoclonal antibodies for a proteomic study being conducted by Science Applications International Corporation – Frederick and the National Cancer Institute.
 
SDI’s antibodies will be used as reference reagents for the Proteomics Reagents & Resources component of the National Cancer Institute’s Clinical Proteomic Technologies for Cancer initiative.
 
“As the study of proteins increases in importance to the research community, we foresee a continued and sustained need for SDI’s expertise in antibodies as they continue to be the most widely used tools for understanding the molecular dynamics underlying disease,” said Matthew Knight, SDI’s president and CEO, in a statement.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.